Literature DB >> 16088919

ATP1A2 mutations in 11 families with familial hemiplegic migraine.

Florence Riant1, Maurizio De Fusco, Paolo Aridon, Anne Ducros, Claire Ploton, Florence Marchelli, Jacqueline Maciazek, Marie Germaine Bousser, Giorgio Casari, Elisabeth Tournier-Lasserve.   

Abstract

Familial hemiplegic migraine (FHM) is an autosomal dominant form of migraine with aura. The disease is caused by mutations of at least three genes among which two have been identified, CACNA1A and ATP1A2. Very few mutations have been identified so far in ATP1A2. We screened the coding sequence of ATP1A2 in 26 unrelated FHM probands in whom CACNA1A screening was negative. A total of eight different mutations were identified in 11 of the probands (41%), including six missense mutations, one small deletion leading to a frameshift, and one in frame deletion. All were novel mutations. Two mutations were recurrent, in three and two families, respectively. Genotyping of 94 relatives of these 11 probands identified 47 mutation carriers, among whom 36 were clinically affected. Sequencing of all 23 exons in an ethnically matched panel detected only one exonic coding polymorphism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16088919     DOI: 10.1002/humu.9361

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  28 in total

1.  Neurological disease mutations compromise a C-terminal ion pathway in the Na(+)/K(+)-ATPase.

Authors:  Hanne Poulsen; Himanshu Khandelia; J Preben Morth; Maike Bublitz; Ole G Mouritsen; Jan Egebjerg; Poul Nissen
Journal:  Nature       Date:  2010-08-15       Impact factor: 49.962

2.  Molecular simulations and free-energy calculations suggest conformation-dependent anion binding to a cytoplasmic site as a mechanism for Na+/K+-ATPase ion selectivity.

Authors:  Asghar M Razavi; Lucie Delemotte; Joshua R Berlin; Vincenzo Carnevale; Vincent A Voelz
Journal:  J Biol Chem       Date:  2017-06-06       Impact factor: 5.157

Review 3.  [Genetics of migraine].

Authors:  T Freilinger; M Dichgans
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

Review 4.  Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS.

Authors:  Sanjeev Rajakulendran; Diego Kaski; Michael G Hanna
Journal:  Nat Rev Neurol       Date:  2012-01-17       Impact factor: 42.937

5.  Ionic leakage underlies a gain-of-function effect of dominant disease mutations affecting diverse P-type ATPases.

Authors:  Maki Kaneko; Bela S Desai; Boaz Cook
Journal:  Nat Genet       Date:  2013-12-15       Impact factor: 38.330

6.  Inhibition of phosphorylation of na+,k+-ATPase by mutations causing familial hemiplegic migraine.

Authors:  Vivien Rodacker Schack; Rikke Holm; Bente Vilsen
Journal:  J Biol Chem       Date:  2011-11-23       Impact factor: 5.157

7.  The structure of the Na+,K+-ATPase and mapping of isoform differences and disease-related mutations.

Authors:  J Preben Morth; Hanne Poulsen; Mads S Toustrup-Jensen; Vivien Rodacker Schack; Jan Egebjerg; Jens Peter Andersen; Bente Vilsen; Poul Nissen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

8.  Recurrent ATP1A2 mutations in Portuguese families with familial hemiplegic migraine.

Authors:  Maria-José Castro; Anine H Stam; Carolina Lemos; José Barros; Raquel G Gouveia; Isabel Pavão Martins; Jan B Koenderink; Kaate R J Vanmolkot; Alexandre P Mendes; Rune R Frants; Michel D Ferrari; Jorge Sequeiros; José M Pereira-Monteiro; Arn M J M van den Maagdenberg
Journal:  J Hum Genet       Date:  2007-10-19       Impact factor: 3.172

9.  Familial and sporadic hemiplegic migraine: diagnosis and treatment.

Authors:  Nadine Pelzer; Anine H Stam; Joost Haan; Michel D Ferrari; Gisela M Terwindt
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

10.  Novel mutations affecting the Na, K ATPase alpha model complex neurological diseases and implicate the sodium pump in increased longevity.

Authors:  Lesley J Ashmore; Stacy L Hrizo; Sarah M Paul; Wayne A Van Voorhies; Greg J Beitel; Michael J Palladino
Journal:  Hum Genet       Date:  2009-05-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.